Skip to content
The Nexus
DossierENTITY

biotech drug trials

Coverage of biotech drug trials in the Nexus archive.

Earliest in view: Jul 16 · 16:38 UTCMost recent: Jul 16 · 16:38 UTC
Co-mentioned in this coverage
Recent coverage
  • BUSINESSJul 16 · 16:38 UTCSEMAFOR
    Kalshi bets on Wall Street

    Kalshi expanded its presence on Wall Street by launching 13 new contracts for betting on biotech drug trial outcomes and expanding contracts tracking AI compute costs. The platform also introduced a Bloomberg terminal-like tool and emphasized institutional financial market integration, including efforts to combat insider trading.

biotech drug trials · Dossier · The Nexus